British drug company launches trial of potential Covid-19 treatment after encouraging early signs

📆 2020/04/15 10:12:00
📰 The Independent

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 59%

日本ニュースニュース

日本最新ニュース,日本見出し

Calquence, a drug used to treat some forms of blood cancer, has shown promise in suppressing the exaggerated immune response that Covid-19 causes in some patients

Related video: Tom Hanks' wife Rita Wilson describes 'extreme' side effects of chloroquine during coronavirus recoveryhas confirmed plans to launch a global clinical trial testing one of its drugs in treating the extreme immune response triggered by Covid-19 in severely ill patients.

コメントを書く

Drug company share holders right now

Reversing the cytokine storm?

Hoping it will work.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。続きを読む:

日本 最新ニュース, 日本 見出し

日本最新ニュース, 日本見出し